Company Description
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally.
It operates through Medical and Non-Medical segments.
The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures.
It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies.
In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles.
Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels.
Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets.
Furthermore, the company provides medical technologies.
It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets.
Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
Country | United States |
IPO Date | Sep 29, 2000 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 10,500 |
CEO | Joseph W. Dziedzic |
Contact Details
Address: 5830 Granite Parkway Plano, Texas United States | |
Website | https://www.integer.net |
Stock Details
Ticker Symbol | ITGR |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001114483 |
CUSIP Number | 45826H109 |
ISIN Number | US45826H1095 |
Employer ID | 16-1531026 |
SIC Code | 3690 |
Key Executives
Name | Position |
---|---|
Joseph W. Dziedzic | President, Chief Executive Officer & Director |
Diron Smith | Executive Vice President & Chief Financial Officer |
Andrew Senn | Senior Vice President of Strategy, Business Development & Investor Relations |
Jim Stephens | President of Cardiac Rhythm Management & Neuromodulation |
John Harris | Executive Vice President of Global Operations & Manufacturing Strategy |
Kirk K. Thor Ph.D. | Executive Vice President & Chief Human Resources Officer |
Margaret Carthy | Executive Vice President of Global Quality & Regulatory Affairs |
McAlister C. Marshall II | Senior Vice President, General Counsel, Chief Ethics & Compliance Officer and Corporate Secretary |
Payman Khales | President of Cardio & Vascular |
Tom P. Thomas | Vice President, Corporate Controller & Principal Accounting Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Oct 24, 2024 | 10-Q | Quarterly Report |
Oct 24, 2024 | 8-K | Current Report |
Oct 02, 2024 | 8-K | Current Report |
Sep 04, 2024 | 4 | Filing |
Aug 01, 2024 | 4 | Filing |
Aug 01, 2024 | 4 | Filing |
Aug 01, 2024 | 4 | Filing |
Jul 25, 2024 | 10-Q | Quarterly Report |
Jul 25, 2024 | 8-K | Current Report |
Jul 15, 2024 | 4 | Filing |